NASDAQ: PALIPalisade Bio Inc Stock Ownership - Who owns Palisade Bio?
Insider buying vs selling
Have Palisade Bio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| John David Finley | CEO CFO | 2026-02-12 | 3,896 | $1.75 | $6.82kSell |
| Mitchell Lawrence Jones | Chief Medical Officer | 2026-02-12 | 1,989 | $1.75 | $3.48kSell |
| Donald Allen Williams | Director | 2026-01-16 | 5,000 | $1.67 | $8.36kBuy |
| Donald Allen Williams | Director | 2026-01-09 | 5,000 | $1.88 | $9.40kBuy |
PALI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when PALI insiders and whales buy or sell their stock.
PALI Shareholders
What type of owners hold Palisade Bio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| B Group Inc | 6.58% | 11,414,285 | $21.57M | Institution |
| Janus Henderson Group PLC | 6.16% | 10,689,452 | $20.20M | Institution |
| Octagon Capital Advisors LP | 5.92% | 10,276,317 | $19.42M | Institution |
| Perceptive Advisors LLC | 5.14% | 8,928,149 | $16.87M | Institution |
| Ameriprise Financial Inc | 5.02% | 8,711,385 | $16.46M | Institution |
| Commodore Capital LP | 4.14% | 7,181,062 | $13.57M | Institution |
| Ra Capital Management LP | 4.10% | 7,124,116 | $13.46M | Institution |
| Franklin Resources Inc | 3.33% | 5,785,189 | $10.93M | Institution |
| Goldman Sachs Group Inc 1 | 3.10% | 5,373,951 | $10.16M | Institution |
| Eversept Partners LP | 2.87% | 4,987,499 | $9.43M | Institution |
PALI vs Biotech Stocks
Palisade Bio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.